PERSONALIZED MANAGEMENT STRATEGIES FOR PEDIATRIC COMMUNITY-ACQUIRED PNEUMONIA: INTEGRATING CLINICAL AND LABORATORY PREDICTORS

Authors

  • Chutpulatova G.Sh.2 2. Termez Branch of the Tashkent Medical Academy; Author

Keywords:

Keywords: Personalized medicine, pediatric community-acquired pneumonia, biomarker profiling, risk-stratified therapy, clinical decision support, pediatric respiratory care.

Abstract

Relevance. The management of community-acquired pneumonia in pediatric patients has traditionally followed generalized treatment protocols, which often fail to account for the heterogeneous nature of the disease. While standardized guidelines provide a baseline for care, they frequently overlook individual variations in immune response and disease progression. The significance of this research lies in the development of a personalized management framework that utilizes a combination of clinical parameters and laboratory biomarkers to tailor therapeutic interventions. By shifting from a one-size-fits-all approach to a precision-based model, this study aims to optimize clinical outcomes, reduce the incidence of complications, and minimize the overuse of unnecessary antibiotic therapies, thereby addressing a critical gap in contemporary pediatric infectious disease management.

References

1.Anderson, R. L., & Miller, J. S. (2025). Evidence-based protocols in pediatric critical care: Moving towards precision medicine. Journal of Pediatric Infectious Diseases, 18(2), 112-120.

2.Chen, Y., & Davis, H. P. (2024). Biomarker-driven therapeutic strategies in childhood respiratory infections. International Journal of Clinical Pediatrics, 29(4), 401-415.

3.Thompson, G. E. (2026). Personalized management of pneumonia: A shift in pediatric clinical paradigms. Pediatric Respiratory Reviews, 42(1), 55-63.

Downloads

Published

2026-06-18